| Application no. and date | 19161388.4 (espacenet) (Federated) (European Patent Register), 20150429 | | Patent/reg. no. and date | DK/EP 3536776, 20231025 | | Publication date | 20190911 | | Priority no. and date | US 201461985589 P, 20140429, US 201461994310 P, 20140516 | | EP pub. no. and date |
EP 3536776 20190911 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 169097/BT/GP | | Inventor | LAUX, Holger, Novartis Pharma AG
Postfach
4002 Basel, CH,
ROMAND, Sandrine, Novartis Pharma AG
Postfach
4002 Basel, CH,
BODENDORF, Ursula, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C12N 15/67 (2006.01) , C12N 15/85 (2006.01) , C12N 15/87 (2006.01) , C12N 5/00 (2006.01) , C12N 5/071 (2010.01) | | Title | HIDTIL UKENDTE VERTEBRATCELLER OG FREMGANGSMÅDER TIL REKOMBINANT EKSPRESSION AF ET POLYPEPTID AF INTERESSE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
